MetaCap

bioAffinity Technologies Earnings

NASDAQ: BIAFHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD

1.65-0.20 (-10.81%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

bioAffinity Technologies earnings summary

In its most recent report on Nov 13, 2026 (Sep/2026), BIAF posted EPS of $-5.89. Revenue for the quarter was $1.1 million. Quarterly EPS is down 108.2% from the same quarter a year earlier.

Summary generated from market data by MetaCap's automated system. Methodology

BIAF earnings history

bioAffinity Technologies reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 13, 2026—$-5.89—-25.0%
Nov 6, 2026—$-3.94—-19.0%
Aug 7, 2026—$-0.64——
May 8, 2026—$-0.81——
Mar 13, 2026—$72.26——
Nov 14, 2025—$-71.05——
Aug 14, 2025—$-5.07——
May 15, 2025—$-4.80——
Mar 31, 2025—$-17.27——
Nov 14, 2024—$-4.84——
Aug 14, 2024—$-0.19——
May 15, 2024—$-0.20——
Apr 1, 2024—$-0.20——
Nov 14, 2023—$-0.26——
Aug 14, 2023—$-0.20——
May 15, 2023—$-0.18——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related